ATV en es it fr

ATV Brand names, ATV Analogs

ATV Brand Names Mixture

  • No information avaliable

ATV Chemical_Formula


ATV RX_link

ATV fda sheet


ATV msds (material safety sheet)

ATV Synthesis Reference

No information avaliable

ATV Molecular Weight

704.856 g/mol

ATV Melting Point

No information avaliable

ATV H2O Solubility

Free base slightly soluble (4-5 mg/mL)

ATV State




ATV Dosage Forms

Capsule (100 mg, 150 mg, or 200 mg)

ATV Indication

For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection.

ATV Pharmacology

Atazanavir (ATV) is an azapeptide HIV-1 protease inhibitor (PI). It is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Atazanavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.

ATV Absorption

Atazanavir is rapidly absorbed with a Tmax of approximately 2.5 hours. Administration of atazanavir with food enhances bioavailability and reduces pharmacokinetic variability

ATV side effects and Toxicity

No information avaliable

ATV Patient Information

ATV Organisms Affected

Human immunodeficiency virus